Valuation: PeptiDream Inc.

Market Cap 138B 876M 764M 722M 655M 1.23B 84.09B 1.23B 8.64B 3.34B 42.75B 3.29B 3.22B P/E 2026 *
20.5x
P/E 2027 * 14.7x
Enterprise Value 124B 793M 691M 653M 593M 1.11B 76.05B 1.11B 7.82B 3.02B 38.66B 2.98B 2.91B EV / Sales 2026 *
3.45x
EV / Sales 2027 * 2.88x
Free-Float
72.25%
Yield 2026 *
-
Yield 2027 * 0.37%
1 day+2.00%
1 week+0.90%
Current month-1.83%
1 month+4.34%
3 months+5.00%
6 months-19.40%
Current year-35.41%
1 week 1,028
Extreme 1028
1,082
1 month 1,028
Extreme 1028
1,155
Current year 906.4
Extreme 906.4
1,788
1 year 906.4
Extreme 906.4
1,793
3 years 906.4
Extreme 906.4
3,060
5 years 906.4
Extreme 906.4
3,840
10 years 906.4
Extreme 906.4
6,540
Manager TitleAgeSince
Chief Executive Officer 51 01/01/2022
Chief Operating Officer - 02/07/2026
Chief Tech/Sci/R&D Officer - 01/04/2024
Director TitleAgeSince
Director/Board Member 51 01/08/2008
Director/Board Member 51 01/09/2017
Director/Board Member 55 01/03/2021
Change 5-day change 1-year change 3-year change Capi.($)
+2.00%+0.90%-36.20%-36.87% 866M
-0.31%+5.79%+48.93%+97.53% 70.89B
+0.39%+2.06%+40.91%+78.49% 62.32B
-3.21%-7.27%-17.73%+351.98% 27.07B
+0.50%+7.13%+29.43%+15.48% 26.2B
-2.64%-0.69%-0.26%-11.90% 24.78B
+0.71%+8.03%+27.22%-13.18% 20.59B
-1.26%-7.81%+169.33%+302.38% 15.52B
-0.22%+3.99%+44.28%+173.35% 14.49B
+0.73%+1.71%-7.18%+886.19% 14.14B
Average -0.33%+1.41%+29.87%+184.34% 27.69B
Weighted average by Cap. -0.48%+1.48%+36.12%+147.63%

Financials

2026 *2027 *
Net sales 36.04B 230M 200M 189M 172M 322M 22.03B 323M 2.26B 874M 11.2B 863M 843M 41.41B 264M 230M 217M 197M 370M 25.32B 371M 2.6B 1B 12.87B 991M 969M
Net income 6.77B 43.1M 37.59M 35.49M 32.23M 60.38M 4.14B 60.63M 425M 164M 2.1B 162M 158M 9.39B 59.8M 52.14M 49.23M 44.71M 83.76M 5.74B 84.11M 590M 228M 2.92B 225M 220M
Net Debt -13.16B -83.87M -73.13M -69.05M -62.71M -117M -8.05B -118M -827M -319M -4.09B -315M -308M -18.42B -117M -102M -96.62M -87.74M -164M -11.26B -165M -1.16B -447M -5.72B -441M -431M
Logo PeptiDream Inc.
PeptiDream Inc. is a Japan-based bio-venture company started by the University of Tokyo and principally engaged in the discovery and development of non-standard peptide therapeutics. The Company operates the Peptide Discovery Platform System (PDPS), a drug development platform system and conducts research and development (R&D) on new drug candidates based on the joint R&D with pharmaceutical companies in Japan and overseas. The Company is involved in the business centered on drug development based on special peptides. The Company's businesses include drug discovery joint R&D, PDPS technology loan (PDPS technology license) and expansion of its own pipeline through strategic alliance (strategic alliance or in-house drug discovery).
Employees
763
Date Price Change Volume
18/09/26 ¥1,070.00 +2.00% 1,049,200
17/09/26 ¥1,049.00 +0.72% 629,000
16/09/26 ¥1,041.50 -1.79% 589,300
15/09/26 ¥1,060.50 +0.33% 521,700
14/09/26 ¥1,057.00 -0.33% 663,500
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
1,070.00JPY
Average target price
2,608.33JPY
Spread / Average Target
+143.77%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4587 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!